» Articles » PMID: 34203116

Smart Health System to Detect Dementia Disorders Using Virtual Reality

Overview
Specialty Health Services
Date 2021 Jul 2
PMID 34203116
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Smart health technology includes physical sensors, intelligent sensors, and output advice to help monitor patients' health and adjust their behavior. Virtual reality (VR) plays an increasingly larger role to improve health outcomes, being used in a variety of medical specialties including robotic surgery, diagnosis of some difficult diseases, and virtual reality pain distraction for severe burn patients. Smart VR health technology acts as a decision support system in the diseases diagnostic test of patients as they perform real world tasks in virtual reality (e.g., navigation). In this study, a non-invasive, cognitive computerized test based on 3D virtual environments for detecting the main symptoms of dementia (memory loss, visuospatial defects, and spatial navigation) is proposed. In a recent study, the system was tested on 115 real patients of which thirty had a dementia, sixty-five were cognitively healthy, and twenty had a mild cognitive impairment (MCI). The performance of the VR system was compared with Mini-Cog test, where the latter is used to measure cognitive impaired patients in the traditional diagnosis system at the clinic. It was observed that visuospatial and memory recall scores in both clinical diagnosis and VR system of dementia patients were less than those of MCI patients, and the scores of MCI patients were less than those of the control group. Furthermore, there is a perfect agreement between the standard methods in functional evaluation and navigational ability in our system where P-value in weighted Kappa statistic= 100% and between Mini-Cog-clinical diagnosis vs. VR scores where P-value in weighted Kappa statistic= 93%.

Citing Articles

Virtual Reality Interventions for Older Adults With Mild Cognitive Impairment: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Yang Q, Zhang L, Chang F, Yang H, Chen B, Liu Z J Med Internet Res. 2025; 27:e59195.

PMID: 39793970 PMC: 11759915. DOI: 10.2196/59195.


"VR is the future": perspectives of healthcare professionals on virtual reality as a diagnostic tool for dementia status in primary care.

Yondjo J, Siette J BMC Med Inform Decis Mak. 2024; 24(1):9.

PMID: 38178165 PMC: 10765843. DOI: 10.1186/s12911-023-02413-y.


Validation of the Computerized Cognitive Assessment Test: NNCT.

Oliva I, Losa J Int J Environ Res Public Health. 2022; 19(17).

PMID: 36078210 PMC: 9518179. DOI: 10.3390/ijerph191710495.


An FGM decomposition-based fuzzy MCDM method for selecting smart technology applications to support mobile health care during and after the COVID-19 pandemic.

Chen T, Lin C Appl Soft Comput. 2022; 121:108758.

PMID: 35345528 PMC: 8941947. DOI: 10.1016/j.asoc.2022.108758.


Recommending Suitable Smart Technology Applications to Support Mobile Healthcare after the COVID-19 Pandemic Using a Fuzzy Approach.

Chen T, Wang Y Healthcare (Basel). 2021; 9(11).

PMID: 34828506 PMC: 8619890. DOI: 10.3390/healthcare9111461.

References
1.
Fernandez Montenegro J, Argyriou V . Cognitive evaluation for the diagnosis of Alzheimer's disease based on Turing Test and Virtual Environments. Physiol Behav. 2017; 173:42-51. DOI: 10.1016/j.physbeh.2017.01.034. View

2.
Geldmacher D, Whitehouse P . Evaluation of dementia. N Engl J Med. 1996; 335(5):330-6. DOI: 10.1056/NEJM199608013350507. View

3.
Han S, Gruhl J, Beckett L, Dodge H, Stricker N, Farias S . Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease. Brain Imaging Behav. 2012; 6(4):610-20. PMC: 3582336. DOI: 10.1007/s11682-012-9177-0. View

4.
Bird C, Chan D, Hartley T, Pijnenburg Y, Rossor M, Burgess N . Topographical short-term memory differentiates Alzheimer's disease from frontotemporal lobar degeneration. Hippocampus. 2009; 20(10):1154-69. DOI: 10.1002/hipo.20715. View

5.
Tu S, Wong S, Hodges J, Irish M, Piguet O, Hornberger M . Lost in spatial translation - A novel tool to objectively assess spatial disorientation in Alzheimer's disease and frontotemporal dementia. Cortex. 2015; 67:83-94. DOI: 10.1016/j.cortex.2015.03.016. View